These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 16882697)

  • 21. Expression and Clinical Significance of Sushi Domain- Containing Protein 3 (SUSD3) and Insulin-like Growth Factor-I Receptor (IGF-IR) in Breast Cancer.
    Zhao S; Chen SS; Gu Y; Jiang EZ; Yu ZH
    Asian Pac J Cancer Prev; 2015; 16(18):8633-6. PubMed ID: 26745129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer.
    Lanigan F; McKiernan E; Brennan DJ; Hegarty S; Millikan RC; McBryan J; Jirstrom K; Landberg G; Martin F; Duffy MJ; Gallagher WM
    Int J Cancer; 2009 May; 124(9):2088-97. PubMed ID: 19142967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The estrogen receptor alpha:insulin receptor substrate 1 complex in breast cancer: structure-function relationships.
    Sisci D; Morelli C; Cascio S; Lanzino M; Garofalo C; Reiss K; Garcia M; Russo A; Andò S; Surmacz E
    Ann Oncol; 2007 Jun; 18 Suppl 6():vi81-5. PubMed ID: 17591841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of wild-type estrogen receptor beta protein in human breast cancer: specific correlation with HER2/neu overexpression.
    Umekita Y; Souda M; Ohi Y; Sagara Y; Rai Y; Takahama T; Yoshida H
    Pathol Int; 2006 Aug; 56(8):423-7. PubMed ID: 16872435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Negligible nuclear FOXP3 expression in breast cancer epithelial cells compared with FOXP3-positive T cells.
    Droeser RA; Obermann EC; Wolf AM; Wallner S; Wolf D; Tzankov A
    Clin Breast Cancer; 2013 Aug; 13(4):264-70. PubMed ID: 23829892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nuclear insulin receptor substrate 1 interacts with estrogen receptor alpha at ERE promoters.
    Morelli C; Garofalo C; Sisci D; del Rincon S; Cascio S; Tu X; Vecchione A; Sauter ER; Miller WH; Surmacz E
    Oncogene; 2004 Sep; 23(45):7517-26. PubMed ID: 15318176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
    Park SS; Kim SW
    Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
    Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
    Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions between FGFR2 and RSK2-implications for breast cancer prognosis.
    Czaplinska D; Mieczkowski K; Supernat A; Skladanowski AC; Kordek R; Biernat W; Zaczek AJ; Romanska HM; Sadej R
    Tumour Biol; 2016 Oct; 37(10):13721-13731. PubMed ID: 27476168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
    Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
    Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invasive lobular and invasive ductal carcinoma of the breast show distinct patterns of vascular endothelial growth factor expression and angiogenesis.
    Lee AH; Dublin EA; Bobrow LG; Poulsom R
    J Pathol; 1998 Aug; 185(4):394-401. PubMed ID: 9828838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of the topographic distribution of ets-1 protein expression in invasive breast carcinomas in relation to tumor phenotype.
    Mylona EE; Alexandrou PT; Giannopoulou IA; Rafailidis PI; Markaki S; Keramopoulos A; Nakopoulou LL
    Cancer Detect Prev; 2006; 30(2):111-7. PubMed ID: 16632244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of BRCA1 protein in breast cancer and its prognostic significance.
    Rakha EA; El-Sheikh SE; Kandil MA; El-Sayed ME; Green AR; Ellis IO
    Hum Pathol; 2008 Jun; 39(6):857-65. PubMed ID: 18400253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunohistochemical study of KiSS1 and KiSS1R expression in human primary breast cancer: Association with breast cancer receptor status, proliferation markers and clinicopathological features.
    Jarzabek K; Koda M; Kozlowski L; Milewski R; Wolczynski S
    Histol Histopathol; 2015 Jun; 30(6):715-23. PubMed ID: 25535062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estrogen receptor alpha gene expression in breast cancer tissues from the Iranian population--a pilot study.
    Hosseini A; Gopalan V; Nassiri M; Ghaffarzadehgan K; Aslaminejad A; Ghovvati S; Smith RA; Lam AK
    Asian Pac J Cancer Prev; 2014; 15(20):8789-91. PubMed ID: 25374208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of ghrelin is correlated to a favorable outcome in invasive breast cancer.
    Grönberg M; Fjällskog ML; Jirström K; Janson ET
    Acta Oncol; 2012 Mar; 51(3):386-93. PubMed ID: 22067021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Angiogenin is up-regulated in the nucleus and cytoplasm in human primary breast carcinoma and is associated with markers of hypoxia but not survival.
    Campo L; Turley H; Han C; Pezzella F; Gatter KC; Harris AL; Fox SB
    J Pathol; 2005 Apr; 205(5):585-91. PubMed ID: 15776477
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2β.
    Raap M; Gronewold M; Christgen H; Glage S; Bentires-Alj M; Koren S; Derksen PW; Boelens M; Jonkers J; Lehmann U; Feuerhake F; Kuehnle E; Gluz O; Kates R; Nitz U; Harbeck N; Kreipe HH; Christgen M
    Lab Invest; 2018 Jan; 98(1):117-129. PubMed ID: 29035379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Co-expression and prognostic value of gross cystic disease fluid protein 15 and mammaglobin in primary breast cancer.
    Fritzsche FR; Thomas A; Winzer KJ; Beyer B; Dankof A; Bellach J; Dahl E; Dietel M; Kristiansen G
    Histol Histopathol; 2007 Nov; 22(11):1221-30. PubMed ID: 17647195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
    van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
    Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.